I‐Ling Chen

778 total citations
47 papers, 518 citations indexed

About

I‐Ling Chen is a scholar working on Surgery, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, I‐Ling Chen has authored 47 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 11 papers in Epidemiology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in I‐Ling Chen's work include Blood Pressure and Hypertension Studies (5 papers), Streptococcal Infections and Treatments (5 papers) and Heart Rate Variability and Autonomic Control (5 papers). I‐Ling Chen is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Streptococcal Infections and Treatments (5 papers) and Heart Rate Variability and Autonomic Control (5 papers). I‐Ling Chen collaborates with scholars based in Taiwan, United States and United Kingdom. I‐Ling Chen's co-authors include Chien‐Te Hsieh, Chen‐Hsiang Lee, Wei-Yu Chen, Lucy C. Fairclough, Ian Todd, Jien-Wei Liu, Chih‐Chung Shiao, Yu–Ming Chang, Anup Roy and Weiyu Chen and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Power Sources.

In The Last Decade

I‐Ling Chen

42 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I‐Ling Chen Taiwan 16 110 74 72 59 56 47 518
Young‐Hoon Yoon South Korea 14 75 0.7× 130 1.8× 42 0.6× 201 3.4× 57 1.0× 63 543
Chan‐Yu Lin Taiwan 20 106 1.0× 188 2.5× 122 1.7× 177 3.0× 115 2.1× 41 1.1k
In Seok Jeong South Korea 16 78 0.7× 352 4.8× 178 2.5× 130 2.2× 198 3.5× 91 911
Xiaoying Lü China 11 103 0.9× 16 0.2× 37 0.5× 40 0.7× 15 0.3× 36 330
Masahiro Miyata Japan 13 116 1.1× 69 0.9× 24 0.3× 41 0.7× 17 0.3× 71 455
Mei‐Chen Lin Taiwan 12 39 0.4× 62 0.8× 18 0.3× 53 0.9× 41 0.7× 76 514
Weibin Zhou China 9 32 0.3× 52 0.7× 27 0.4× 12 0.2× 22 0.4× 26 539
Shinichi Sugiyama Japan 18 39 0.4× 247 3.3× 135 1.9× 140 2.4× 127 2.3× 65 1.0k
Jens Hartmann Austria 16 37 0.3× 116 1.6× 260 3.6× 63 1.1× 50 0.9× 61 743
Mohammad Montazeri Iran 11 23 0.2× 63 0.9× 34 0.5× 51 0.9× 32 0.6× 23 694

Countries citing papers authored by I‐Ling Chen

Since Specialization
Citations

This map shows the geographic impact of I‐Ling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Ling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Ling Chen more than expected).

Fields of papers citing papers by I‐Ling Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Ling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Ling Chen. The network helps show where I‐Ling Chen may publish in the future.

Co-authorship network of co-authors of I‐Ling Chen

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Ling Chen. A scholar is included among the top collaborators of I‐Ling Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Ling Chen. I‐Ling Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsieh, Chong‐Chao, Hsuan‐Fu Kuo, I‐Ling Chen, et al.. (2025). Plumbagin improves pulmonary vascular remodeling in PAH via miR-21-5p/MMP/TIMP regulation, with diagnostic implications for cardiac function. Biomedicine & Pharmacotherapy. 192. 118604–118604.
2.
Benjamin, Joel S., Abigail Jarret, Shashank Bharill, et al.. (2024). Abstract 2375: 23ME-01473, a novel anti-ULBP6/2/5 monoclonal antibody, reinvigorates anti-tumor NK cell function through NKG2D and FcγRIIIa activation. Cancer Research. 84(6_Supplement). 2375–2375. 1 indexed citations
3.
Lin, Ting‐Lung, Yueh‐Wei Liu, Ying‐Ju Chen, et al.. (2024). Gram-negative bacterial infections in surgical intensive care unit patients following abdominal surgery: high mortality associated with Stenotrophomonas maltophilia infection. Antimicrobial Resistance and Infection Control. 13(1). 65–65. 2 indexed citations
4.
Chen, I‐Ling & Hsien‐Yi Chiu. (2023). Association of herpes zoster with COVID-19 vaccination: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. 89(2). 370–371. 5 indexed citations
5.
Chen, I‐Ling, et al.. (2023). VHH CDR-H3 conformation is determined by VH germline usage. Communications Biology. 6(1). 864–864. 18 indexed citations
6.
Lai, Yu‐Hung, Wei‐Lun Liu, Tsung‐Ying Lee, et al.. (2022). Magnolol regulates miR-200c-3p to inhibit epithelial–mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo. Phytomedicine. 110. 154597–154597. 5 indexed citations
7.
Chen, I‐Ling, et al.. (2022). The Risk of Bleeding and Adverse Events with Clopidogrel in Elective Hip and Knee Arthroplasty Patients. Journal of Clinical Medicine. 11(7). 1754–1754. 4 indexed citations
8.
Chen, I‐Ling, Ian Todd, Patrick J. Tighe, & Lucy C. Fairclough. (2020). Electronic cigarette vapour moderately stimulates pro-inflammatory signalling pathways and interleukin-6 production by human monocyte-derived dendritic cells. Archives of Toxicology. 94(6). 2097–2112. 16 indexed citations
9.
Chen, I‐Ling, et al.. (2020). Interactions between carbapenems and valproic acid among the patients in the intensive care units. Journal of Critical Care. 62. 151–156. 10 indexed citations
10.
11.
Chang, Yu–Ming, et al.. (2020). Heart rate variability as an independent predictor for 8-year mortality among chronic hemodialysis patients. Scientific Reports. 10(1). 881–881. 25 indexed citations
12.
Chen, I‐Ling, et al.. (2018). Prediction of imipenem-resistant microorganisms among the nosocomial critically ill patients with Gram-negative bacilli septicemia: a simple risk score. Infection and Drug Resistance. Volume 11. 283–293. 7 indexed citations
13.
Huang, Ya-Ting, et al.. (2017). Heart rate variability during hemodialysis is an indicator for long-term vascular access survival in uremic patients. PLoS ONE. 12(3). e0172212–e0172212. 8 indexed citations
14.
Chang, Yu–Ming, et al.. (2016). Impact of metabolic syndrome and its components on heart rate variability during hemodialysis: a cross-sectional study. Cardiovascular Diabetology. 15(1). 16–16. 15 indexed citations
15.
Chang, Ya‐Wen, et al.. (2015). Antimicrobial stewardship: A review of audit and feedback systems and evaluation of outcomes in a medical center in Taiwan. Journal of Microbiology Immunology and Infection. 48(2). S63–S63.
16.
Chang, Yu–Ming, et al.. (2015). Heart rate variability is an indicator for intradialytic hypotension among chronic hemodialysis patients. Clinical and Experimental Nephrology. 20(4). 650–659. 24 indexed citations
17.
Chen, Yawei, I‐Ling Chen, I‐Ching Lin, & Shou‐Yen Kao. (2014). Prognostic value of hypercalcaemia and leucocytosis in resected oral squamous cell carcinoma. British Journal of Oral and Maxillofacial Surgery. 52(5). 425–431. 15 indexed citations
18.
Kuo, Kuang-Che, Ying‐Hsien Huang, I‐Ling Chen, et al.. (2014). Are antibiotics beneficial to children suffering from enterovirus infection complicated with a high C-reactive protein level?. International Journal of Infectious Diseases. 25. 100–103. 2 indexed citations
19.
Chen, I‐Ling, et al.. (2013). Adenocarcinoma Not Otherwise Specified in the Maxilla Mimicking a Benign Sinonasal Cystic Lesion-A Case Report. 24(1). 50–57.
20.
Liebert, Monica, et al.. (1999). Urothelial Differentiation and Bladder Cancer. Advances in experimental medicine and biology. 462. 437–448. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Young‐Hoon Yoon Breakdown of academic impact, for papers by Chan‐Yu Lin Breakdown of academic impact, for papers by In Seok Jeong Breakdown of academic impact, for papers by Xiaoying Lü Breakdown of academic impact, for papers by Masahiro Miyata Breakdown of academic impact, for papers by Mei‐Chen Lin Breakdown of academic impact, for papers by Weibin Zhou Breakdown of academic impact, for papers by Shinichi Sugiyama Breakdown of academic impact, for papers by Jens Hartmann Breakdown of academic impact, for papers by Mohammad Montazeri
Rankless by CCL
2026